Wearable Cardiac Monitoring Devices Market by Product Type (ECG/Heart Rate Patches, Smartwatches with ECG, Wearable Holter Monitors, Chest Straps & Others), by Application (Arrhythmia Detection, Heart Failure Management, Post-Surgical Monitoring, Fitness & Wellness Monitoring), by End User (Homecare/Direct-to-Consumer, Hospitals & Clinics, Ambulatory Cardiac Centers), by Distribution Channel (Direct-to-Consumer/Retail, Hospital Procurement, Online Channels), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035
St. Catharines, Ontario, 14 Nov 2026 — Vectomat Insights has published a new report titled ‘Wearable Cardiac Monitoring Devices Market by Product Type, Application, End User, Distribution Channel, and Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035.’ The Global Wearable Cardiac Monitoring Devices market was valued at USD 2,187.4 Mn in 2025 and is projected to reach USD 7,597.9 Mn by 2035, growing at a CAGR of 13.26% during the forecast period 2026–2035, according to Vectomat Insights.
ECG/heart rate patches take the biggest slice of 2025 revenue at 42.0%, but smartwatches with ECG are the ones to watch: they compound at 17.87% a year as Apple, Samsung and Huawei push FDA- and MFDS-cleared cardiac features onto the wrist.
The global wearable cardiac monitoring devices market was worth USD 2,187.4 Mn in 2025 and reaches USD 7,597.9 Mn by 2035 at a 13.26% CAGR. ECG/heart rate patches lead product revenue with 42.0%, smartwatches with ECG grow fastest at 17.87% a year, North America holds 37.0% of demand and homecare buyers already account for 48.0% of spending.
Key Insights Snapshot
| Metric | Value |
|---|---|
| Report Title | Global Wearable Cardiac Monitoring Devices Market Size, Share, Growth & Forecast By Product Type, Application, End User, and Distribution Channel, 2026–2035 |
| Base Year Market Size | USD 2,187.4 Mn (2025) |
| Forecast Market Size | USD 7,597.9 Mn (2035) |
| CAGR | 13.26% |
| Forecast Period | 2026–2035 |
| Dominant Region | North America (37.0%) |
| Fastest-Growing Region | Asia Pacific |
| Dominant Segment | ECG/Heart Rate Patches (42.0%) |
| Dominant Application | Arrhythmia Detection |
| Report Format | |
| Publisher | Vectomat Insights |
What Medical Device Leaders Need to Know About the Wearable Cardiac Monitoring Devices Market
Hospital CIOs: Hospitals & Clinics still buy 32.0% of devices, but iRhythm's USD 287.5 Mn VitalConnect deal shows patch data is heading into inpatient and hospital-to-home workflows. Budget for integration and cybersecurity now; iRhythm's June 2026 breach is the warning case.
Cardiology and Electrophysiology Leads: Arrhythmia Detection is 39.8% of 2025 revenue, and the referral funnel increasingly starts on a consumer wrist. Expect more smartwatch-triggered workups and plan triage pathways that separate true AF from noise.
Device-Company Strategy Heads: Smartwatches with ECG grow at 17.87% a year against 9.92% for patches. Prescription players need either a consumer on-ramp or deeper hospital acuity coverage; standing still in the patch category means losing share.
Payer and Health-Plan Medical Directors: Medicare's 2026 fee schedule added remote monitoring codes for 2 to 15 days of data, lowering the bar for short studies. Watch utilisation closely, since homecare spending already makes up 48.0% of the market.
Investors and Corporate Development Teams: Wearlinq's USD 14 Mn Series A in December 2025 and iRhythm's VitalConnect purchase point to two exits: scale clinical-grade multi-lead hardware, or sell into a platform. Heart Failure Management, growing at 15.71%, is where acquirers are looking next.

What Is the Wearable Cardiac Monitoring Devices Market?
Wearable Cardiac Monitoring Devices Market refers to skin-worn and wrist-worn devices that record heart rhythm or heart rate outside the hospital, from prescription ECG patches and wearable Holter recorders to smartwatches with an FDA-cleared ECG app. Why now? Cardiac monitoring has stopped being a clinic appointment. A patient can get a Zio patch in the mail, a smartwatch can flag possible atrial fibrillation overnight, and as of January 2026 Medicare pays for remote monitoring periods as short as two days. That's moving 48.0% of spending into homecare already. For device makers, the question isn't whether monitoring leaves the hospital; it's who owns the data once it does.
How Is the Wearable Cardiac Monitoring Devices Market Segmented?
ECG/heart rate patches take the biggest slice of 2025 revenue at 42.0%, worth USD 918.7 Mn, because every long-term study is billed as a full diagnostic service. But the wrist is catching up. Smartwatches with ECG grow at 17.87% a year and pass patches in value around 2030. By application, Arrhythmia Detection leads at 39.8%, while Heart Failure Management is the clinical use to watch at 15.71% a year. Homecare buyers already make up 48.0% of spending, and HeartBeam's December 2025 clearance for a home 12-lead ECG shows where that's heading.
This report segments the Wearable Cardiac Monitoring Devices market as follows:
- By Product Type: ECG/Heart Rate Patches, Smartwatches with ECG, Wearable Holter Monitors, Chest Straps & Others
- By Application: Arrhythmia Detection, Heart Failure Management, Post-Surgical Monitoring, Fitness & Wellness Monitoring
- By End User: Homecare/Direct-to-Consumer, Hospitals & Clinics, Ambulatory Cardiac Centers
- By Distribution Channel: Direct-to-Consumer/Retail, Hospital Procurement, Online Channels
- By Region: North America, Europe, Asia Pacific, Latin America, The Middle East, Africa
Browse the full Wearable Cardiac Monitoring Devices Market report →

Which Region Leads the Wearable Cardiac Monitoring Devices Market?
North America leads with 37.0% of 2025 revenue, worth USD 809.3 Mn, and the U.S. accounts for USD 631.3 Mn of it on the back of reimbursed long-term ECG studies and new 2026 remote monitoring codes. Europe holds 27.0%, with Germany its largest market at USD 171.3 Mn. Asia Pacific, at 24.0%, is the fastest-growing region: South Korea is set to grow 15.5% a year and Japan 13.6%, as Samsung and Garmin win cardiac clearances from MFDS. Latin America (5.0%), the Middle East (4.0%) and Africa (3.0%) are smaller markets where hospital groups, not consumers, buy first.

Why Is the Wearable Cardiac Monitoring Devices Market Growing?
Undiagnosed Atrial Fibrillation Burden — About 59.7 million people live with atrial fibrillation or flutter worldwide, and many don't know it. That hidden pool is why Arrhythmia Detection takes 39.8% of 2025 revenue.
Smartwatch ECG Goes Mainstream — Cleared ECG apps now ship on Apple, Samsung, Google, Garmin and Huawei watches. Smartwatches with ECG grow at 17.87% a year, the fastest product type.
Reimbursement for Short Home Monitoring — Medicare's 2026 fee schedule pays for remote monitoring periods of just 2 to 15 days. Homecare buyers already take 48.0% of spending.
AI Interpretation Clears More Conditions — AliveCor's Kardia 12L reached 39 FDA-cleared AI determinations in January 2026. More cleared findings per recording means more clinical value per device.
Adding VitalConnect extends our cardiac monitoring platform beyond ambulatory care into inpatient and hospital-to-home settings, widening the patients we can reach.
What's Limiting the Wearable Cardiac Monitoring Devices Market?
Software Failures and Recall Risk — A Philips telemetry service application failed to flag ECG alerts and drew an FDA Class I recall in January 2025. Two deaths were reported.
False Alerts and False Reassurance — Consumer alerts can mislead in both directions. Researchers warned in February 2026 that a silent watch doesn't rule out disease.
Cybersecurity and Data Liability — Hackers stole patient cardiac data from iRhythm via a third-party app in June 2026. Every connected patch is now a security asset.
Even with software and security risks in view, Vectomat Insights expects the market to grow from USD 2,187.4 Mn in 2025 to USD 7,597.9 Mn by 2035.
What Industry Leaders Are Saying About the Wearable Cardiac Monitoring Devices Market
A missing alert from the watch doesn't rule out hypertension, so patients can come away falsely reassured when the feature's sensitivity is low.
With 39 FDA-cleared determinations, Kardia 12L brings near hospital-grade 12-lead interpretation to the point of care and the home.
Clinically validated ECG devices provide reliable data that help healthcare professionals make decisions, and Faros Pro strengthens our offering in international long-term ECG recording markets.
Report Segmentation & Scope
| Vectomat Insights | Market & Reports — Report Segmentation & Scope | |
|---|---|
| Scope Included in the Study | |
| By Product Type |
|
| By Application |
|
| By End User |
|
| By Distribution Channel |
|
| Regional Analysis | |
| North America | The U.S., Canada, Mexico |
| Europe | Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe |
| Asia Pacific | China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific |
| Latin America | Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America |
| The Middle East | GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East |
| Africa | South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa |
| Note: The scope can be further tailored as per your specific requirement. Contact sales@vectomatinsights.com | |
Who Are the Leading Companies in the Wearable Cardiac Monitoring Devices Market?
Key players operating in the Global Wearable Cardiac Monitoring Devices market include iRhythm Technologies (U.S.), Apple (U.S.), Samsung Electronics (South Korea), Philips (Netherlands), Boston Scientific (U.S.), Garmin (U.S.), AliveCor (U.S.), Google (Fitbit) (U.S.), Withings (France), Bittium (Finland), Omron Healthcare (Japan), Huawei (China), VitalConnect (U.S.), HeartBeam (U.S.) and Biotricity (U.S.). It's a two-speed field, and the gap is narrowing. Prescription specialists like iRhythm and Philips win on reimbursed studies, while Apple, Samsung and Huawei win on reach. iRhythm's August 2026 deal for VitalConnect shows the clinical side is buying breadth, not just volume. Bittium and HeartBeam are the hardware specialists to watch.
What's New in the Wearable Cardiac Monitoring Devices Market?
August 2026 — iRhythm Technologies: Agreed to acquire wearable biosensor company VitalConnect for about USD 287.5 Mn, adding the VitalPatch platform with up to 30 days of continuous monitoring across 11 physiological parameters.
August 2026 — Bittium: Launched the Faros Pro ambulatory ECG recorder with the EasyFlex single-use one-lead patch, CE marked under EU MDR for recordings from 24 hours to 30 days.
January 2026 — AliveCor: Received FDA clearance for new KAI 12L determinations on the Kardia 12L ECG system, bringing the total to 39 cardiac determinations.
December 2025 — Wearlinq: Raised a USD 14 Mn Series A led by AIX Ventures to scale its eWave continuous wireless multi-lead ECG wearable.
December 2025 — HeartBeam: Received FDA 510(k) clearance for a cable-free synthesized 12-lead ECG system for at-home arrhythmia assessment, after a successful appeal.
September 2025 — Apple: Received FDA clearance for Hypertension Notifications on Apple Watch, launched with watchOS 26.
Frequently Asked Questions
What is the size of the global wearable cardiac monitoring devices market?
The global wearable cardiac monitoring devices market was worth USD 2,187.4 Mn in 2025 and is projected to reach USD 7,597.9 Mn by 2035, a 13.26% CAGR over 2026–2035. ECG/heart rate patches lead with 42.0% of revenue, while smartwatches with ECG grow fastest at 17.87% a year. Homecare and direct-to-consumer buyers already account for 48.0% of spending, and that share keeps rising as studies move out of the clinic, according to Vectomat Insights.
What is driving growth in the wearable cardiac monitoring devices market?
Three forces drive growth. About 59.7 million people worldwide live with atrial fibrillation or flutter, many undiagnosed, so longer monitoring finds more cases. Cleared ECG apps now ship on watches from Apple, Samsung, Google, Garmin and Huawei. And Medicare's 2026 fee schedule pays for home monitoring periods as short as two days, which makes short post-discharge studies billable for the first time, according to Vectomat Insights.
Which region leads the wearable cardiac monitoring devices market?
North America leads with a 37.0% share in 2025, worth USD 809.3 Mn, and the United States alone is a USD 631.3 Mn market growing at 12.1% a year. Europe follows at 27.0%, led by Germany, and Asia Pacific holds 24.0%. Asia Pacific is the fastest-growing region, with South Korea compounding at 15.5% a year and Japan at 13.6% as consumer brands win cardiac clearances, according to Vectomat Insights.
Which product type dominates the wearable cardiac monitoring devices market?
ECG/heart rate patches are the largest product type at 42.0% of 2025 revenue, or USD 918.7 Mn, because each long-term continuous monitoring study is billed as a full diagnostic service. Smartwatches with ECG hold 30.0% but grow at 17.87% a year to USD 3,397.4 Mn by 2035, passing patches around 2030. Wearable Holter monitors take 18.0% and chest straps 10.0%, according to Vectomat Insights.
Who are the leading companies in the wearable cardiac monitoring devices market?
Leading companies include iRhythm Technologies, Apple, Samsung Electronics, Philips, Boston Scientific, Garmin, AliveCor, Google (Fitbit), Withings, Bittium, Omron Healthcare, Huawei, VitalConnect, HeartBeam and Biotricity. iRhythm leads prescription patches and agreed to buy VitalConnect for about USD 287.5 Mn in August 2026. Apple, Samsung and Huawei lead consumer ECG watches, and Huawei passed Apple in global smartwatch share in 2025, according to Vectomat Insights.
How can I access the full VMI Wearable Cardiac Monitoring Devices market report?
The full report covers 300+ pages with 98 tables and 72 figures, including segment revenue for 2023–2025, forecasts to 2035, 35+ country views and profiles of 15 companies. You can request a free sample or buy the report on the Vectomat Insights website, ask for up to 10% free customization, or contact the sales team at sales@vectomatinsights.com for pricing and licence terms, according to Vectomat Insights.
Access the Complete Wearable Cardiac Monitoring Devices Market Report
300+ pages | Global coverage | PDF | 2026
Contact: sales@vectomatinsights.com
About Vectomat Insights
Vectomat Insights is an independent market research firm. Our analysts build every market model in-house, from company revenues, government and regulatory data, and interviews with industry participants, and each report is reviewed by a senior analyst and fact-checked before publication.
Contact: Vectomat Insights | Email: sales@vectomatinsights.com | Website: www.vectomatinsights.com · +1 416-876-0312